UA
32
3
CINF
56
2
LOW
55
2
ABBV
50
4
EQIX
65
2
FRT
53
3
BBY
46
-3
TXT
68
3
APH
58
3
XOM
62
2
PAYX
50
5
TSCO
48
-7
EQT
57
7
ADI
56
4
PFE
26
3
AAP
35
-3
PXD
53
3
UPS
48
3
MU
38
3
SJM
28
5
UA
32
3
CINF
56
2
LOW
55
2
ABBV
50
4
EQIX
65
2
FRT
53
3
BBY
46
-3
TXT
68
3
APH
58
3
XOM
62
2
PAYX
50
5
TSCO
48
-7
EQT
57
7
ADI
56
4
PFE
26
3
AAP
35
-3
PXD
53
3
UPS
48
3
MU
38
3
SJM
28
5
Financhill
Back

Amphastar Pharmaceuticals Quote, Financials, Valuation and Earnings

This trade could move overnight Thursday!

Access my free presentation on these overnight trades right here
Sell
50

AMPH
Amphastar Pharmaceuticals

Last Price:
40.92
Seasonality Move:
14.6%

7 Day Trial

ALL ACCESS PASS

$ 7

Election Shock on August 19th?

Click here now to see the evidence I've gathered.

Amphastar Pharmaceuticals Price Quote

$40.92
+0.73 (+1.82%)
(Updated: April 23, 2024 at 6:55 PM ET)

Amphastar Pharmaceuticals Key Stats

Sell
50
Amphastar Pharmaceuticals (AMPH) is a Sell
Day range:
$39.93 - $40.75
52-week range:
$35.62 - $67.66
Dividend yield:
0%
P/E ratio:
15.46
P/S ratio:
3.31
P/B ratio:
3.02%
Volume:
302.9K
Avg. volume:
383.1K
1-year change:
-8.33%
Market cap:
$1.9B
Revenue:
$644.4M
EPS:
$2.58

How Much Does Amphastar Pharmaceuticals Make?

Is Amphastar Pharmaceuticals Growing As A Company?

Amphastar Pharmaceuticals Stock Price Performance

What Is Amphastar Pharmaceuticals 52-Week High & Low?

Amphastar Pharmaceuticals Price To Free Cash Flow

Is It Risky To Buy Amphastar Pharmaceuticals?

Is Amphastar Pharmaceuticals Cash Flow Positive?

  • What Is AMPH Cash Flow From Operations?
    Cash flow from operations (TTM) is $183.5M
  • What Is Amphastar Pharmaceuticals’s Cash Flow From Financing?
    Cash flow from financing (TTM) is $454.1M
  • What Is Amphastar Pharmaceuticals’s Cash Flow From Investing?
    Cash flow from investing (TTM) is -$649.1M

Amphastar Pharmaceuticals Return On Invested Capital

  • Is Management Doing A Good Job?
    AMPH return on invested capital is 14.38%
  • What Is Amphastar Pharmaceuticals Return On Assets?
    ROA measures how assets are converting to revenues and is 11.56%
  • What Is AMPH Return On Equity?
    ROE is a measure of profitability and is 23.71%

Amphastar Pharmaceuticals Earnings Date & Stock Price

Amphastar Pharmaceuticals Competitors

Amphastar Pharmaceuticals Dividend Yield

Data Unavailable

Amphastar Pharmaceuticals Analyst Estimates

YoY Growth Past Surprise
EPS: 3.03% -3.3%
Revenue: 31.91% 2.76%

Analyst Recommendations

Buy Recommendations: 2
Hold Recommendations: 2
Sell Recommendations: 0
Price Target: 62.60
Upside from Last Price: 55.76%

Major Shareholders

  • How many AMPH shares are owned by institutional investors?
    58.7M AMPH shares are owned by institutional investors
  • How many AMPH shares are owned by insiders?
    1.1M AMPH shares are owned by insiders